Your SlideShare is downloading. ×
Unit 8 chapter 44 diabetes mellitus
Upcoming SlideShare
Loading in...5

Thanks for flagging this SlideShare!

Oops! An error has occurred.

Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Unit 8 chapter 44 diabetes mellitus


Published on

Published in: Health & Medicine
1 Like
  • Be the first to comment

No Downloads
Total Views
On Slideshare
From Embeds
Number of Embeds
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

No notes for slide


  • 1. Unit 8: The Endocrine System Chapter 44: Drugs for Diabetes Mellitus
  • 2. Pancreas
    • Describe the secretory function of the pancreas.
    • Which pancreatic cells are essential to the endocrine function?
    • Why is the endocrine function of the pancreas so important?
  • 3. Insulin
    • Secretion regulated by chemical, hormonal, and neural factors
    • Key to metabolic process in most body cells
    • Transport vehicle for glucose (except brain)
    • Why does glucose not need a transport vehicle into brain cells?
    • What is the most important regulator of insulin secretion? (Think about the negative feedback loop)
  • 4. Contributors to Glucose Homeostasis
    • Hyperglycemic effects
    • Hormones
      • Epinephrine
      • Thyroid hormone
      • Growth hormone
      • conticosteroids
    • Drugs
      • Phenytoin
      • NSAIDs
      • Diuretics
      • Steroids
    • Hypoglycemic effects
    • Drugs
      • Alcohol
      • Lithium
      • ACE Inhibitors
      • Beta-adrenergic blockers
  • 5. Diabetes Mellitus
    • Chronic metabolic disorder characterized by hyperglycemia
    • Etiology: combination of genetic and environmental factors
    • Increasing incidence
    • Group of disorders caused by:
      • Deficient to absent insulin secretion
      • Decreased insulin receptor sensitivity
  • 6. Type I Diabetes Mellitus
    • Usually presents during childhood
    • Aka: insulin dependent diabetes mellitus
    • Etiology:
      • autoimmune destruction of pancreatic beta cells
      • Interaction of genetic, immunologic, and environmental factors
    • Consistent presenting signs/symptoms
      • Hyperglycemia, polyuria, polyphagia, polydipsia, glycosuria, weight loss, fatigue
  • 7. Potential Complications
    • Arterial damage
    • Altered peripheral circulation
    • Nerve degeneration
    • Impaired lipid metabolism
  • 8. Pharmacotherapy for Type I Diabetes Mellitus
    • What are the current options for Insulin therapy?
    • What is the therapeutic goal and desired outcome of insulin therapy?
    • What additional measures are used with insulin pharmacotherapy to control Type 1 DM?
  • 9. Insulin Therapy
    • Fundamental Principle:
    • “ the right amount of insulin must be available to cells when glucose is available in the blood.”
    • What is the consequence of administering insulin when glucose is not available?
    • What is the consequence of forgetting or skipping scheduled insulin dosage?
  • 10. Insulin Therapy
    • What is the primary adverse effect of insulin therapy?
    • Other adverse effects include:
      • Localized allergic reaction
      • Generalized urticaria
      • Swollen lymph glands
  • 11. Hypoglycemia (Insulin Reaction)
    • Symptoms occur when there is more insulin in the blood than needed.
    • Causes:
      • Insulin levels peak during exercise
      • Received too much insulin
      • Skipped meal after taking dose of insulin
    • May be treated with glucagon
      • Can cause response in ≤ 20 min
  • 12. Somogyi Phenomenon
    • Rapid decrease in blood glucose (typically at night)
    • Stimulates release of hormones that increase blood glucose
    • Morning blood glucose is elevated
  • 13. Types of Insulin
    • Most insulin given today is human insulin
    • Human insulin has been modified to produce a more rapid onset or longer duration. (Insulin Analogs)
    • Classified as rapid, short, intermediate, or long acting
  • 14. Nursing Considerations
    • What are nursing considerations for insulin therapy?
    • What must the nurse be familiar with?
    • What teaching must be included?
  • 15. Type 2 Diabetes Mellitus
    • Major type of diabetes mellitus
    • Endogenous insulin present in deficient amounts
    • Fundamental problem
      • Insulin resistance
    • Poor management results in same complications as Type 1 diabetes mellitus
    • Recommendation: preprandial glucose < 110 mg/dl
  • 16. Oral Hypoglycemics
    • Lower blood sugar
    • Some may cause hypoglycemia
    • Classified based on structure and mechanism of action
    • Initially monotherapy
    • Insulin may need to be added to regimin
    • Some combination drugs are available. Why?
  • 17. Classes of Hypoglycemic Agents
    • Sulfonylureas
    • Biguanides
    • Alpha-glucosidase Inhibitors
    • Thiazolidinediones
    • Meglitinides
    • New drugs
    • Develop a table to compare and contrast
  • 18. Incretin-Glucose Control Mechanism
    • Incretin is a hormone secreted by the intestines in response to a meal when blood glucose is elevated.
    • Increased incretin levels signals the pancreas to increase insulin secretion and the liver to stop producing glucagon.
    • Why is this important?
  • 19. exenatide (Byetta)
    • Mimics the action of incretin
    • Causes increased secretion of insulin, slows absorption of glucose, and reduces action of glucagon
    • Subcutaneously 1-2 times per day
    • Adverse effects:
      • Significant nausea, vomiting, diarrhea
  • 20. Additional New Drugs
    • Dipeptidyl peptidase – 4 (DPP4) Inhibitors
      • Sitagliptin phosphate (Januvia)
      • Inhibits destruction of incretin
    • pramlinitide (Symlin)
      • Resembles pancreatic hormone amylin
      • Assists with glucose regulation
        • Slows absorption of glucose
        • Inhibits action of glucagon
  • 21. Nursing Considerations
    • What are the nursing considerations for hypoglycemic agents?
    • What needs to be included in teaching?